Isomorphic Labs in Talks for About $5 Billion in Funding

Alphabet's Isomorphic Labs is negotiating to secure about $5 billion in funding to advance its AI-driven drug discovery initiatives. This capital raise aims to bolster the company's efforts in leveraging artificial intelligence for pharmaceutical research.